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Abstract
Background: Although canine clinical manifestations of 
Lyme disease vary widely, cutaneous manifestations are not 
well documented in dogs. In contrast, a variety of cutaneous 
manifestations are reported in human Lyme disease caused by the 
spirochete Borrelia burgdorferi. A recently recognized dermopathy 
associated with tickborne illness known as Morgellons disease 
is characterized by brightly-colored filamentous inclusions and 
projections detected in ulcerative lesions and under unbroken 
skin. Recent studies have demonstrated that the dermal filaments 
are collagen and keratin biofibers produced by epithelial cells 
in response to spirochetal infection. We now describe a similar 
filamentous dermatitis in canine Lyme disease. 
Methods and Results: Nine dogs were found to have cutaneous 
ulcerative lesions containing embedded or projecting dermal 
filaments. Spirochetes characterized as Borrelia spp. were 
detected in skin tissue by culture, histology, immunohistochemistry, 
polymerase chain reaction (PCR) and gene sequencing performed 
at five independent laboratories. Borrelia DNA was detected either 
directly from skin specimens or from cultures inoculated with skin 
specimens taken from the nine canine study subjects. Amplicon 
sequences from two canine samples matched gene sequences 
for Borrelia burgdorferi sensu stricto. PCR amplification failed to 
detect spirochetes in dermatological specimens from four healthy 
asymptomatic dogs.
Conclusions: Our study provides evidence that a filamentous 
dermatitis analogous to Morgellons disease may be a manifestation 
of Lyme disease in domestic dogs. 
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Introduction
Dogs are the domestic animals most susceptible to Lyme disease 
(LD), and serve as both sentinels and as animal models to investigate 
tickborne illnesses [1-4]. Acute signs of LD caused by the spirochete 
Borrelia burgdorferi (Bb) – general malaise, fever, swelling of lymph 
nodes and pain – are non-specific, can disappear within a few days, 
and may be overlooked by the dog’s owner, leading to chronic, 
disseminated LD in some dogs [2,5,6]. 
Weeks to months after infection–when Bb has disseminated into 
skin, joints and connective tissue–intermittent lameness associated 
with fatigue and moderate increase in body temperature is reported 
[2,5,6]. Neurological and cardiac manifestations are less frequent 
findings, while glomerulonephritis and renal tubular necrosis are 
described in some breeds–most commonly in Golden and Labrador 
Retrievers [7,8]. Cutaneous manifestations of Lyme disease in dogs are 
not well documented. Erythema migrans, the “bullseye” rash described 
in humans, is not reported in canine infections; however, dogs may 
develop a small reddish lesion approximately 1 cm in diameter around 
the tick bite, and this is thought to be an inflammatory response to the 
bite rather than to the Lyme spirochete [2,5,6].
Morgellons disease (MD) is a human dermopathy characterized 
by spontaneously-appearing, slowly-healing skin lesions containing 
filaments that are often extraordinarily colorful (blue, white, black, 
green, purple, pink and red) and lie under, are embedded in, or 
project from skin [9-17]. Many medical professionals consider MD to 
be a delusional disease and attribute the presence of colorful filaments 
to excoriation coupled with accidental or deliberate implantation 
of textile fibers [18,19]. In contrast, dermatopathology studies 
suggest that the filaments may lie under or project from unbroken 
skin, making it highly unlikely that they are self-implanted [9-17]. 
Furthermore, the unusual filaments are composed of keratin and 
collagen, and blue coloration in filaments is the result of melanin 
pigmentation, as shown by specific histological staining [14,15]. 
The unusual filaments can be visualized in skin under 50X–100X 
magnification and some filaments fluoresce under ultraviolet (UV) 
light, thus aiding the identification of MD cases [9-13]. 
Musculoskeletal and neurocognitive symptoms associated with 
Lyme disease and tickborne coinfections are frequently reported in 
this group of patients, and MD patients demonstrate seroreactivity 
to Bb antigens [12-14]. Histological, electron microscopic and PCR 
studies of dermatological tissue containing filamentous inclusions 
and/or projections derived from MD patients verified the presence 
of Bb sensu stricto (Bbss) and Bb sensu lato (Bbsl) spirochetes in 
MD clinical specimens [15-17]. Motile spirochetes characterized 
by molecular means as Borrelia spp were also cultured from MD 
skin, blood and vaginal specimens, indicating viability and systemic 
infection and suggesting that MD is a manifestation of LD [15,16]. 
These detailed molecular and histological studies confirm that MD is 
a true somatic infectious illness and not a delusional disorder [15-17]. 
We describe nine canine cases of Borrelia spirochetal infection 
associated with a wide variety of Lyme-like symptoms, including 
dermopathy with filamentous inclusions and/or projections. To 
our knowledge this is the first detailed description of canine clinical 
illness matching human MD.
Materials and Methods
Study subjects
Clinical histories for the dogs and their owners were obtained by 
two of the authors (GMR and JLM). Dermatological samples were 
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collected at the Heartland Veterinary Clinic, Airdrie, AB, Canada. 
Written informed consent for participation in the study was obtained 
from all dog owners. Approval for sample testing was obtained from 
the Western Institutional Review Board, Puyallup, WA, and the 
Institutional Review Board of the University of New Haven, West 
Haven, CT.
Microscopic examination for dermal filaments
The presence of dermal filaments was confirmed in two ways: 
(1) either directly on the pet with a hand-held 50X microscope 
equipped with both a white LED light and a UV light, and/or (2) in 
dermal specimens removed from the animal and examined with a 
brightfield microscope at either 50X or higher magnification or with 
a microscope illuminated from above the specimen with white LED 
or UV light. Sectioned embedded or protruding filaments were also 
observed in some tissue sections with brightfield microscopy. 
Cultures
Cultures were obtained using Barbour–Stoenner–Kelly H 
(BSK-H) complete medium containing 6% rabbit serum (Sigma 
Aldrich, #B8291) and the antibiotics phosphomycin (0.02 mg/l) 
(Sigma Aldrich), rifampicin (0.05 mg/l) (Sigma Aldrich), and 
amphotericin B (2.5 μg/l) (Sigma-Aldrich), as described previously 
[20]. Culture medium was inoculated with dermatological tissue 
removed from the dog by a scalpel blade and placed directly into 
the medium in the examination room. Cultures were incubated 
in a microaerophilic environment at 32°C, and culture fluid was 
examined by dark-field microscopy for spirochetes weekly for a 
total of 4 weeks of incubation. Cultures were processed for PCR 
by centrifuging the fluid at 10,000g for 25 minutes to concentrate 
spirochetes, retaining the pellet and discarding the supernatant. 
DNA was extracted using Qiagen DNeasy® Blood and Tissue Kits, 
prior to shipping. Culture fluid smears were fixed onto Superfrost 
plus® slides (Thermo Scientific) with acetone at -20°C for special 
staining.
Gömöri trichrome staining, dieterle staining and anti-Bb 
immunostaining
Dermatological specimens and/or culture smears were processed 
for histological and special staining at McClain Laboratories LLC, 
Smithtown, NY. Dermatological specimens were formalin-fixed, 
paraffin-blocked and sectioned for staining. Gömöri trichrome 
staining was performed as previously described [15]. Formalin-fixed 
dermatological sections and acetone-fixed culture slides were stained 
with silver nitrate using a standard Dieterle method, and anti-Bb 
immunostaining was performed as described previously [21]. Positive 
and negative controls of anti-Bb immunostains were prepared for 
comparison purposes using liver sections from uninfected mice and 
mice experimentally inoculated with Bb, as previously described [21]. 
Additional negative controls were: Gram-positive and Gram-negative 
commensal bacteria, normal human skin, human psoriasis skin, 
and human fungal-infected skin. For anti-Bb immunostaining, the 
following protocol was used: specimens on slides were reacted with 
unconjugated rabbit anti-Bb polyclonal antibody (Abcam ab20950) 
followed by incubation with an alkaline phosphatase probe (Biocare 
Medical #UP536L) then by a chromogen substrate (Biocare Medical 
#FR805CHC) and counterstained with hematoxylin. Optimal 
antibody dilutions were determined by titration. In addition, Dieterle 
staining and anti-Bb immunostaining was performed on a scab from 
control dog CC-1. 
Molecular testing
PCR - University of New Haven, West Haven, CT: DNA from 
tissue was obtained by overnight lysis in 180 μl tissue lysis buffer 
(Qiagen) and 20 μl Proteinase K (Qiagen) at 56°C in a shaking 
water bath, followed by phenol/chloroform extraction the next day. 
Extracted DNA was suspended in 50-100 μl 1X TE buffer. 
A TaqMan assay targeting a 139-bp fragment of the gene encoding 
the Borrelia 16S rRNA was used for the real-time detection of Borrelia 
DNA [22]. Final volumes of 20 μl with 900 nM of each primer, 200 
nM of probe, and 10 μl of 2X TaqMan Universal PCR Master Mix 
(Applied Biosystems) were used and amplifications were conducted 
on a CFX96 Real-Time System (Bio-Rad) with cycling conditions 
of 50°C for 2 minutes, 95°C for 10 minutes, followed by 40 cycles 
of 95°C for 15 seconds and 60°C for 60 seconds. Fluorescent signals 
were recorded using CFX96 Real-Time software and Cq threshold 
automatically set. Reactions were performed in triplicate concurrently 
with positive (Bb sensu stricto strain B-31) and negative (water) 
controls. Reactions with additional negative controls (water, normal 
human foreskin, normal skin from two Lyme patients, and normal 
skin from one Morgellons patient) were performed to assure the 
accuracy and specificity of the assays. Borrelia DNA was not detected 
in any of the negative controls.
 Nested PCR with primers for the 16S rRNA and pyrG genes 
was performed as previously described [22-25]. “Outer” primers 
were used in the first reaction and “inner” primers were used for the 
nested reaction, with 1 μl of PCR product from the first reaction used 
as template for the second [25]. Cycling parameters were as follows: 
94°C for 5 minutes followed by 40 cycles of denaturation at 94°C for 1 
minute, annealing for 1 minute (temperature based on the primer set 
used), and extension at 72°C for 1 minute, with a final extension step 
at 72°C for 5 minutes. PCR products were visualized on 1-2% agarose 
gels. For samples with amplicons that had DNA of suitable quality, 
Sanger sequencing was performed.
PCR - Australian Biologics, Sydney, Australia: Bb detection 
by real-time PCR targeting the 16S rRNA gene and endpoint PCR 
targeting the rpoC gene was performed as previously described 
[17,26] using the Eco™ Real-Time PCR system with software version 
3.0.16.0. DNA was extracted from tissue using the QIAamp 96 DNA 
Mini QIAcube HT (Qiagen). Runs were performed in duplicate with 
positive (Vircell Amplirun Borrelia DNA) and negative controls 
using primers for the Borrelia 16S rRNA gene target [17]. Thermal 
profiles for analyses were performed as follows: polymerase activation 
for 10 minutes at 95°C then PCR cycling for 40 cycles of 10 seconds 
at 95°C dropping to 60°C sustained for 45 seconds. The magnitude 
of the PCR signal generated (ΔR) for each sample was interpreted as 
positive or negative when compared to positive and negative controls. 
Eluted water was also included with the negative controls to confirm 
non-contamination of extraction. Extraction control (Bioline BIO-
3532) was used as an internal control and to confirm the efficiency 
of the extraction. Threshold levels are automatically set by the Eco™ 
system. Negative control runs showed no change in the magnitude of 
the PCR signals, indicating the absence of detectable Borrelia DNA. 
For samples with amplicons that had DNA of suitable quality, Sanger 
sequencing was performed.
PCR - Mount Allison University, New Brunswick, Canada: 
Tissue samples were placed in a microcentrifuge tube with 200 μl 
of AquaGenomic solution (Multitarget Pharmaceuticals). The tissue 
was homogenized with a micropestle and digested with 0.5 μl (10 
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Results
Clinical histories
Samples were collected from nine dogs with dermatological lesions 
and four randomly selected control dogs without dermatological 
pathology. The control dogs (two males and two females) were a West 
Highland White Terrier, a Whippet-Border Collie cross, a Beagle cross 
and a Golden Retriever. None of the control dogs had evidence of LD. 
Clinical histories for the nine affected dogs are summarized in Table 
1. The pet owners’ familiarity with MD is summarized in Table 2. 
Brief clinical summaries are outlined below.
Case C-1: In 2013, a 6-year-old male neutered English Bulldog 
presented at Heartland Veterinary Clinic. The dog had a history of tick 
exposure in Alberta, Canada. Clinical symptoms began in December 
2012 and included spontaneously-appearing ulcerative skin lesions, 
weight gain, personality change (from friendly to aggressive), and later 
(mid July 2013) the development of a severe urinary tract infection. 
Painful, pruritic lesions first developed on the head and between toes, 
then spread to his back (Figure 1A). 
In February 2013, the dog was referred to a veterinarian specialist 
in dermatology and was diagnosed with atopic dermatitis. 
Staphylococcus pseudointermedius was identified from a skin 
culture and allergy testing indicated an allergy to mugwart. Various 
treatments including topical antibiotics, antiseptic solutions, 
antifungal agents, steroids and topical cyclosporine resulted in 
little benefit. 
In August 2014, multicolored fibers were noted to be projecting 
from the skin lesions, and the similarity of this condition to MD as 
described in humans was recognized. The dog’s owners were not 
familiar with either LD or MD and had not noticed the microscopic 
dermal filaments. Gross microscopic examination revealed both 
embedded and protruding multicolored dermal filaments (white, 
pink, bluish purple and teal) (Figure 1B). These fibers fluoresced 
under UV light. Samples of skin were taken for histological studies 
and Borrelia culture, and serological testing was negative. However, 
confirmation of spirochetal infection resulted from the techniques 
described in this study. 
The dog was then treated with antibiotic therapy targeting LD. 
He was first treated with doxycycline, but an allergy to this antibiotic 
resulted in a switch to cephalexin. The condition responded very 
well. A relapse occurred when antibiotic therapy was halted and 
necessitated resumption of therapy, this time with metronidazole and 
azithromycin. Other treatments included a short course of prednisone 
for swelling in the interdigital glands, and topical cyclosporine with 
μg) of proteinase K, and the samples were incubated at 60°C for 2 
hours, then 95°C for 10 minutes. The digested sample was vortexed 
and centrifuged at 12,000g for 5 minutes. The supernatant (~180 μl) 
was removed and the DNA precipitated with 0.8vol of isopropanol. 
Following mixing, the samples were centrifuged at 12,000g for 5 
minutes and the supernatant discarded. The tubes were rinsed twice 
with 70% ethanol, the pellet dried and DNA resuspended in 100 μl of 
1mM Tris-HCl (pH 7.6) and stored at -20°C. 
Nested PCR was used to test for B. burgdorferi OspC and 
membrane protein BB 0006 (AAC66397.2/ WP_002658381.1). 
Primers were as follows:
Primer Forward Reverse
OspC 
Outside
GTA ATA ATT CAG GGA 
AAG ATGG
CAG CAC CTT TAG TTT TAG 
TAC C
OspC 
Inside
CTA ATG CGG TTT TAC 
TTG CTG
GTT TTT AAA ATG GCT TCT TTT 
GC
BB 0006 
Outside
GCT CAA GAA TAT TTC 
CAA TCA AC
GTC GAT ATA AAG TTG ATA GTT 
CTG
BB 0006 
Inside
CAG CTA ATA TGG ATC 
CAA TGC
GCT GTT GTA TTT TTT GCT TTC 
AG
For the first round, each reaction contained 12.5 μl of GoTaq® 
Green Master Mix (Promega), 8.5 μl of nuclease free water, 1 μl of 
each outside primer and 2 μl of extracted DNA. Reactions for the 
second round were set up similarly but used inside primers and 2 μl 
of product from the first round as the input DNA. The program for 
the nested PCR reaction was an initial denaturing at 95°C for 5 
minutes followed by denaturing at 95°C for 15 seconds, annealing 
at 55°C (outside primers) or 58°C (inside primers) for 60 seconds 
and extension at 72°C for 45 seconds, repeated for 35 cycles, 
with a final extension at 72°C for 5 minutes. All PCR reactions 
were run with multiple  negative controls to detect aerosol or 
solution contamination. 
PCR products were visualized on a 1.2% (w/v) SB-agarose 
gel containing 5 μl of 10,000 X SYBR Safe stain (Edvotek #608). A 
GeneDireX 100bp DNA ladder was run alongside the PCR products 
to allow for size determination (GeneDireX, DM001-R500). Gels were 
imaged using a Fluor-S MultiImager or a DyNA Light Dual Intensity 
UV Transilluminator. Nested PCR products of appropriate size and 
quantity were sent to Nanuq (McGill University and Genome Quebec 
Innovation Center) for sequencing. Resulting chromatograms were 
analyzed using 4 Peaks. Consensus sequences were determined 
and imported into SeaView [27] for alignment.  DNA extraction, 
PCR reactions and gel electrophoresis were all performed in 
different rooms. To control for amplicon contamination, the primers 
were designed for this experiment and had not been previously used. 
ID# Breed Age, years Sex (Neutered, Spayed) Serology Residence
C-1 English Bulldog 6 Male (N) IFA and SNAP 4Dx® negative (IDEXX) Alberta, Canada
C-2 English Bulldog 7.8 Female (S) Not performed Alberta, Canada
C-3 Golden Retriever 5 Female (S) SNAP 4Dx® negative (IDEXX) Colorado, USA
C-4 Miniature Schnauzer 7.8 Female (S) Not performed Alberta, Canada
C-5 Bullie 3 Male Not performed Texas, USA
C-6 Chihuahua 6.5 Male (N) SNAP 4Dx® negative (IDEXX) Kentucky, USA
C-7 Miniature Schnauzer 6 Female (S) Not performed Alberta, Canada
C-8 English Bulldog 5.8 Female (S) Not performed Alberta, Canada
C-9 BeaglePug 0.6 Female (N) Not performed Alberta, Canada
Table 1:&DQLQHVXEMHFWGDWD,)$LPPXQRÀXRUHVFHQFHDVVD\61$3';®, enzyme linked immunosorbent assay (ELISA) for heartworm disease, ehrlichiosis, Lyme 
disease and anaplasmosis.
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dog C-1. Because of the previous experience, filamentous borrelial 
dermatitis was suspected. Examination with a dermatoscope 
revealed the presence of white, pink, bluish-purple, and teal fibers 
protruding from unbroken skin. These fibers fluoresced under UV 
light. Examination of dermatological specimens revealed pink, blue 
and white fibers. Based on the experience with dog C-1, dog C-2 
was promptly treated with doxycycline and cephalexin, and her skin 
lesions resolved completely. 
Case C-3: In 2005, a 5-year-old spayed female Golden Retriever 
presented at an undisclosed veterinary clinic located in Colorado, 
USA, with pruritic nodular and ulcerative lesions. The dog had a 
history of tick exposure in Colorado. She was diagnosed with allergic 
dermatitis concurrent with secondary staphylococcal infection, 
and she had been treated for her condition for the past 4 years by 
her current veterinarian. Symptoms had waxed and waned during 
that time period, generally worsening during summer months. 
Ongoing treatment included prednisone and antibiotic therapy given 
primarily during summer months with doxycycline, metronidazole, 
cefpodoxime and a topical spray containing gentamicin and 
betamethasone. There was significant improvement with this 
treatment. The dog’s owner had a history of MD and reported to her 
veterinarian that the dog was similarly afflicted. She requested that 
the attending veterinarian submit specimens for this study. 
The attending veterinarian was amenable to further investigation, 
took two punch biopsies from afflicted areas of skin and collected 
dermatological detritus from the dog’s lesions that were then 
submitted for study. Serological evidence of LD by the SNAP 4Dx® test 
(IDEXX Laboratories, Westbrook, ME) was negative. Dermatological 
specimens revealed projecting and embedded multi-colored (white 
and blue) filaments. As a result of this study, treatment with oral 
antibiotics was restarted. To date, this therapy has helped though not 
eliminated the condition. 
Case C-4: A 7.8-year-old spayed female Miniature Schnauzer 
presented at Heartland Veterinary Clinic. The dog had a history 
of tick exposure in Alberta, Canada. Symptoms included hair loss 
accompanied by crusty, pruritic and painful lesions, on the back and 
ketoconazole for management of pruritic symptoms. The skin lesions 
resolved over several months (Figure 1C), and the dog’s personality 
reverted back to friendliness. 
Case C-2: In December 2014, a spayed female 7.8-year-old 
English Bulldog (same owners as dog C-1), presented at Heartland 
Veterinary Clinic with lesions similar to those seen in dog C-1. The 
dog had a history of tick exposure in Alberta, Canada, similar to 
ID # Owner had lesions diagnosed as MD
Owner had prior knowledge 
of MD
C-1 No No
C-2 No No
C-3 Yes Yes
C-4 No No
C-5 Yes Yes
C-6 Yes Yes
C-7 No No
C-8 No No 
C-9 No No
Table 2: Pet owner familiarity with Morgellons disease (MD).
Figure 1A: Painful pruritic lesions on back of dog C-1.
Figure 1B*URVVPLFURVFRSLFYLHZRIPXOWLFRORUHGGHUPDO¿ODPHQWVIURP
dog C-1.
Figure 1C: Back of dog C-1 following antibiotic treatment showing resolution 
of skin lesions.
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sides. Under magnification with a 50X hand-held microscope, white, 
pink, bluish-purple and teal fibers that fluoresced under UV light 
were seen in the skin lesions. As a result of this study, she was treated 
with a cephalosporin antibiotic for four months, and the lesions 
resolved. The dog subsequently left the care of Heartland Veterinary 
Clinic due to relocation of her owners to a different city, and her 
long-term clinical outcome is unknown. The owners had very limited 
knowledge of LD and no prior knowledge of MD.
Case C-5: A 3-year-old male Bullie (Pit Bull/Staffordshire Terrier 
cross) presented at a veterinary clinic in Spring, Texas, USA in early 
2015. The dog had a history of tick exposure in Texas. Primary 
symptoms included welts and ulcerative skin lesions on his back 
associated with hair loss, and intense pruritus severe enough that it 
caused him to dig at his skin. Symptoms started when he was about 
one-year-old. The attending veterinarian considered allergies and 
skin infection in the differential diagnosis. However, the dog’s owner 
suffers from MD symptoms and after explaining the similarities 
between his condition and his dog’s, the veterinarian was amenable 
to including the dog in this study. Gross microscopic examination 
revealed dermal filaments. The dog was treated with doxycycline 
and metronidazole, plus prednisone to alleviate symptoms. This 
treatment was effective in reducing, but not completely eliminating, 
the dermopathy. 
Case C-6: For several years, a 6.5-year-old neutered male 
Chihuahua had symptoms that started when the dog and his owner 
resided in Kentucky, USA, where the dog had been exposed to ticks. 
Symptoms included dermopathy that began with the development 
of black specks, discolored skin, and swelling around his anus 
and penis. The owner reported changes to the dog’s hair with the 
texture becoming coarse, hair loss where lesions were present, and 
the projection of unusual filaments from afflicted areas of skin. 
Other symptoms included depression, gastrointestinal problems, 
and the lack of an anal sphincter reflex. The presence of lesions, 
skin discoloration, and neuropathy were noted and confirmed by a 
veterinarian in Kentucky. 
The dog was sent to various specialists including a neurologist. 
Various topical treatments failed, and tests including a negative 
SNAP 4Dx® revealed no useful clinical information. Microscopic 
examination of a dermatological specimen revealed embedded 
filaments, predominantly white. Although spirochetal infection was 
detected during the course of this study, the dog and owner moved 
to another city and have not yet found a veterinarian who is willing 
to try antibiotic therapy. The owner also has symptoms of MD and is 
familiar with the condition.
Case C-7: A 6-year-old salt-and-pepper spayed female Miniature 
Schnauzer presented at Heartland Veterinary Clinic in July 2015. The 
dog had a history of tick exposure in Alberta, Canada. She was spayed 
in August 2014 and vaccinated in September 2014 by her regular 
veterinarian. During that period of time her skin was reported to be 
normal. She was referred by her regular veterinarian to Heartland 
Veterinary Clinic in July 2015 after she developed numerous small, 
pruritic sores on her back. She was treated with prednisone and 
amoxicillin without benefit. By August 2015 the skin lesions had 
worsened and examination with a dermatoscope revealed white, 
pink, bluish purple and teal fibers that fluoresced under UV light. Her 
treatment was changed to doxycycline and a topical triamcinolone-
neomycin-nystatin-gramicidin cream, and after two weeks on this 
regimen her skin returned to normal. An update by her owner in 
January 2016 revealed that her skin had remained free of lesions until 
very recently. She currently has only one small lesion, and antibiotic 
therapy will be resumed.
Case C-8: In July 2015 a 5.8-year-old spayed female English 
Bulldog presented at Heartland Veterinary Clinic with dermatitis 
and an ear infection. The dog had a history of tick exposure in 
Alberta, Canada. She was treated with oral trimeprazine tartrate 
and prednisolone for the dermatitis and started treatment with oral 
cephalexin and marbofloxacin-clotrimazole-dexamethasone eardrops 
for the ear infection. Testing for thyroid function was normal. 
She returned in early January 2016 with worsening dermatitis, 
patchy hair loss and pruritus. Examination with a 50X hand-held 
microscope revealed pink and blue embedded and projecting dermal 
filaments. She was not tested for Lyme disease. Treatment with 
doxycycline was started. On her follow-up visit in late January 2016, 
she showed marked improvement and her skin lesions had healed. 
There were a few blue dermal filaments that were visible under UV 
fluorescence. 
She continued to take doxycycline for three months. Although 
the skin lesions cleared, pruritus persisted. The antibiotic was 
discontinued, and she has continued oral trimeprazine tartrate and 
prednisolone without recurrence of the lesions.
Case C-9: A 5-month-old spayed female beagle/pug cross was 
seen at Heartland Veterinary Clinic with worsening alopecia. The dog 
had a history of tick exposure in Alberta, Canada. She was diagnosed 
with Demodex infestation in September 2015, and she was treated for 
pruritus and mild alopecia with topical imidacloprid and moxidectin. 
Her skin symptoms resolved by December 2015, but alopecia recurred 
in March 2016. She was negative for mites, but examination with a 
50X hand-held microscope revealed pink and blue dermal projecting 
and embedded dermal filaments that fluoresced under ultraviolet 
light. Based on this finding, the dog was treated with doxycycline and 
her skin lesions resolved over three months.
Evidence of dermal filaments
Dermatological findings in the nine dogs are summarized in 
Table 3. Dogs C-1, C-2, C-4, C-7, C-8 and C-9 were examined with a 
50X hand-held microscope for in situ verification of dermal filaments. 
Unusual multicolored filaments (white, pink, bluish-purple and teal) 
projecting from skin lesions under LED white light were observed 
in these dogs. Unusual filaments projecting from skin lesions that 
fluoresced brightly under UV illumination were observed in dogs 
C-1, C-2, C-4, C-7, C-8 and C-9. 
Using 100X magnification, gross dermatological specimens from 
dogs C-1 to C-9 demonstrated embedded and projecting filaments 
approximately 10-40 μm in diameter. Embedded multicolored 
filaments (white, pink, blue and teal) were observed in dermatological 
scrapings from dogs C-1, C-8 and C-9. Blue and white filaments were 
observed in dermatological scrapings from dogs C-2 and C-3, and 
white filaments were detected in dogs C-4 to C-7. Dermatological 
specimens collected from all subjects demonstrated embedded, white, 
unusual filaments at 100X magnification that fluoresced under UV 
light. 
Dermatological specimens from dogs C-3 and C-4 had additional 
coarse black dermal filaments that were thicker than normal canine 
hair. The black filaments from dog C-3 had been firmly attached to 
the skin, and were plucked out by the attending veterinarian with 
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difficulty and then submitted for study. Microscopic examination 
at 1000X revealed that the black fibers were coarse and had scaling 
consistent with hairs. The follicular bulbs revealed deformities with 
multiple hairs originating from a single bulb, and/or multiple bulbs 
fused together (Figure 2).
Dog C-1 had large areas of dermopathy, and sections prepared 
for histological studies contained filamentous inclusions suitable for 
performing Gömöri trichrome staining to confirm the collagen and 
keratin composition of filaments. The dermatological specimens revealed 
embedded filaments that consisted of a hollow medulla surrounded by 
a solid cortex, morphologically consistent with the filaments seen in 
human MD tissue. Some sectioned filaments stained green, indicating 
collagen composition (Figure 3), and some stained irregularly with both 
green and red indicating both keratin and collagen content. 
A dermatological specimen from dog C-5 stained with anti-Bb 
immunostain revealed a fiber with a nucleated shaft (Figure 4). The 
nuclei stained blue and were more concentrated towards the point of 
origin of the fiber. A coiled red-staining spirochete was attached to 
the fiber shaft (Figure 4).
Microscopic examination of dermatological sections for 
evidence of infection
Microscopic findings for evidence of infection in dermatological 
samples from the nine dogs are summarized in Table 4.
Dieterle staining: Stained slides were examined at 400X and 
1000X magnification. Silver nitrate staining revealed slender bacteria 
or spherules morphologically consistent with Borrelia spirochetes, 
as well as granular forms (spherules) in histological sections of 
dermatological tissue obtained from dogs C-1 to C-3 and C-5 to C-7. 
Staining in tissue sections often showed jagged spirochetes, as seen in 
the section from dog C-7 (Figure 5A). Dieterle staining of a scab from 
control dog CC-1 was negative (Figure 5B).
Anti-Bb immunostaining: Stained slides were examined at 400X 
and 1000X magnification. Anti-Bb immunostaining demonstrated 
cherry-red, strongly-positive staining in histological sections of 
dermatological tissue obtained from C1, C-2, C-3, C-5 and C-6. Staining 
was weaker though positive on sections from dog C-4. In sections 
from dogs C-1 and C-3, well-defined spirochetes were clearly visible, 
particularly in sections from C-1 (Figure 5C). Positive extracellular 
staining was present in tissue, probably due to secreted Borrelia antigens 
and/or lysis of Borrelia spirochetes. Anti-Bb immunostaining of a scab 
from control dog CC-1 was negative (Figure 5D).
Microscopic examination of culture
Darkfield examination of fluid: BSK-H fluid was inoculated 
with dermatological tissue from dogs C-1, C-2, C-4, C-7, C-8 and 
C-9. After incubation for four weeks, the cultures were examined with 
darkfield microscopy at 400X and/or 1000X magnification, revealing 
predominantly spherules approximately 0.1 to 1 μm diameter and 
occasional motile spirochetes, some with visible helical morphology, 
approximately 0.5 μm diameter and 10-15 μm long in the culture 
fluid, as seen in the sample from dog C-1 (Figure 6A).
ID ,QVLWX;PDJQL¿FDWLRQ Gross examination 100X 100X examination of sectioned embedded ¿ODPHQWV
C-1 White, pink, bluish-purple and teal projecting ¿EHUVWKDWÀXRUHVFHGXQGHU89OLJKW
(PEHGGHGEOXHUHGDQGZKLWH¿ODPHQWVWR
μm in diameter
Filamentous inclusions with hollow medulla and 
solid cortex; Gömöri trichrome determined keratin 
and collagen composition
C-2 White, pink, bluish-purple and teal projecting ¿EHUVWKDWÀXRUHVFHGXQGHU89OLJKW
$WWDFKHGEOXHDQGZKLWH¿ODPHQWVWRPLQ
diameter 
C-3
(PEHGGHGEOXHDQGZKLWH¿ODPHQWVWRPLQ
diameter; coarse black hairs with visible scaling and 
deformed follicular bulbs; thickened hyperkeratotic 
IROOLFXODUFDVWVZLWKEOXH¿ODPHQWRXVSURMHFWLRQV
C-4 White, pink, bluish-purple and teal projecting ¿EHUVWKDWÀXRUHVFHGXQGHU89OLJKW
(PEHGGHGZKLWH¿ODPHQWRXV¿EHUVWRPLQ
diameter; deformed hair follicles
C-5 (PEHGGHGZKLWH¿ODPHQWRXVLQFOXVLRQVWRPin diameter 
Filamentous inclusions 10 to 40 μm in diameter 
ZLWKKROORZPHGXOODDQGVROLGFRUWH[RQH¿EHU
nucleated shaft towards bulb, losing nuclei farther 
away from point of origin
C-6 (PEHGGHGZKLWH¿ODPHQWVWRPLQGLDPHWHU Filamentous inclusions 10 to 40 μm in diameter with hollow medulla and solid cortex 
C-7 White, pink, bluish-purple and teal projecting ¿EHUVWKDWÀXRUHVFHGXQGHU89OLJKW (PEHGGHGZKLWH¿ODPHQWVWRPLQGLDPHWHU
Filamentous inclusions 10 to 40 μm in diameter 
with hollow medulla and solid cortex 
C-8 White, pink, bluish-purple and teal projecting ¿EHUVWKDWÀXRUHVFHGXQGHU89OLJKW
C-9 3LQNDQGEOXHSURMHFWLQJ¿EHUVWKDWÀXRUHVFHGunder UV light
Table 3:8QXVXDOGHUPDWRORJLFDO¿QGLQJVDQG¿ODPHQWYHUL¿FDWLRQ
Figure 2: Dermatological specimen from dog C-3 showing coarse black 
GHUPDO¿ODPHQWVZLWKPXOWLSOHKDLUVRULJLQDWLQJIURPDVLQJOHEXOEDQGRU
multiple bulbs fused together. 1000X.
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Dieterle staining: Stained culture smears for samples from C-1, 
C-2, C-4 and C-7 were examined at 400X and 1000X magnification. 
Silver nitrate staining revealed spherules and longer bacteria 
morphologically consistent with Borrelia spp., as seen in the sample 
from dog C-4 (Figure 6B). 
Anti-Bb immunostaining: Stained culture smears for C-1, 
C-2, C-4 and C-7 were examined at 400X and 1000X magnification. 
Anti-Bb immunostaining demonstrated cherry-red, strongly-
positive staining with spherules and longer bacteria morphologically 
consistent with Borrelia spp., as seen in the sample from dog C-4 
(Figure 6C). 
Molecular testing
Dermatological specimens from the nine affected dogs and four 
control dogs were submitted for PCR detection of Borrelia DNA at 
three independent laboratories: Mt Allison University, Sackville, NB; 
University of New Haven, West Haven, CT; and Australian Biologics, 
Sydney, Australia. These samples included dermatological tissue 
and/or DNA extracted from skin culture pellets. The positive results 
for DNA amplification of Borrelia DNA targets are summarized in 
Table 5. All samples were run with positive and negative controls. 
Borrelia DNA was not detected in any of the control dogs at the three 
independent laboratories (Table 6).
Amplicon sequences from dermatological tissue were obtained 
from dogs C-3 and C-7, and BLAST analysis of the forward and 
reverse sequences are shown in Figure 7. The amplicon sequence 
from dog C-3 demonstrated 99% homology with the B. burgdorferi 
sensu stricto strain B31 pyrG gene (Figure 7A and 7B). The amplicon 
sequence from dog C-7 demonstrated 99% homology with the B. 
burgdorferi sensu stricto strain B31 16S gene (Figure 7C and 7D).
Discussion
In this study, we describe nine dogs presenting at veterinary 
Figure 3:'HUPDWRORJLFDOVSHFLPHQIURPGRJ&VKRZLQJ¿ODPHQWVWKDW
stained green, indicating collagen composition. Gömöri trichrome stain, 
1000X.
Figure 4:'HUPDWRORJLFDO VSHFLPHQ IURPGRJ&VKRZLQJD ¿EHUZLWK
a nucleated shaft and attached red-staining spirochete. Anti-Borrelia 
immunostain, 1000X.
Figure 5A: Dieterle silver staining of dermatological specimen from dog 
C-7 showing spirochete morphologically consistent with Borrelia. 1000X.
Figure 5B: Dieterle silver staining of dermatological specimen from 
control dog CC-1 showing absence of spirochetes. 1000X.
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Figure 5C: Anti-Borrelia immunostaining of dermatological specimen 
from dog C-1 showing  cherry-red stained spirochete. 1000X.
Figure 5D: Anti-Borrelia immunostaining of dermatological specimen from 
control dog CC-1 showing absence of spirochetes. 1000X.
Figure 6C: Anti-Borrelia LPPXQRVWDLQLQJ RI GHUPDWRORJLFDO FXOWXUH ÀXLG
from dog C-4 showing spirochetes morphologically consistent with 
Borrelia. 1000X
Figure 6A:'DUN¿HOGPLFURVFRS\RIGHUPDWRORJLFDOFXOWXUHÀXLGIURPGRJ
&VKRZLQJPRWLOHÀXRUHVFHQWVSLURFKHWH;
Figure 6B:'LHWHUOHVLOYHUVWDLQLQJRIGHUPDWRORJLFDOFXOWXUHÀXLGIURPGRJ
C-4 showing spirochetes morphologically consistent with Borrelia. 1000X
clinics with unusual filamentous dermatological manifestations of 
LD. The key diagnostic criterion of a comparable human condition, 
MD, is the presence of filaments projecting from ulcerative lesions 
and/or embedded in unbroken skin [14,15]. The filaments associated 
with MD, which are often vividly colored, are both keratin and 
collagen in composition and are produced by proliferative activated 
epithelial keratinocytes and fibroblasts, respectively [14,15]. The blue 
coloration seen in some filaments is contained within granules and is 
melanin in composition [15]. Morgellons patients frequently describe 
changes in hair and other keratinized tissues [13,14]. Sectioned 
filamentous inclusions in specimens from case C-1 were verified 
to be of collagen and/or keratin composition, as shown by Gömöri 
trichrome staining. Nuclei were observed in the shaft of a filament 
from a specimen obtained from case C-5. The presence of nuclei and 
the composition of the fibers proves cellular origin and thus the fiber 
could not be a textile. The specimen was comparable to nucleated 
filaments seen in human MD dermatological specimens.
As in humans afflicted with MD, the microscopic filaments seen in 
the canine cases were predominantly white, blue and red. However, in 
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cases C-3 and C-4, in addition to blue and white microscopic filaments, 
thickened coarse black fibers were also present, and microscopic 
examination revealed scaling and follicular bulbs consistent with 
hair structures, thus indicating keratin composition. Dermatological 
specimens from dogs C-3 and C-4 also displayed deformed follicles. 
These abnormal hairs and deformed hair follicles were identical to the 
hair deformities described previously in a human MD patient [12]. 
Canine MD is complicated by the fact that a dog’s undercoat can hide 
filamentous inclusions or projections. Examination of the skin with a 
50X han-dheld microscope under UV light was helpful in identifying 
canine MD; unlike normal canine hair, the filaments fluoresced and 
clearly projected up from the skin surface. 
In addition to meeting the key diagnostic criterion for MD, 
the canine cases paralleled human MD in that Borrelia spirochetal 
infection was associated with the filament formation. Spirochetes 
identified as Borrelia spp. were detected in and/or cultured from 
samples taken from the dermatological lesions of the canine subjects. 
Given that these cases demonstrated both ulcerative lesions with 
unusual filament formation associated with Borrelia spirochetal 
infection, they are entirely analogous to human MD. Since MD-type 
filamentous lesions are associated with LD in humans, recognition of 
these lesions could aid in the diagnosis of LD in animals.
In all animals tested in our study, commercial serological testing 
was negative for Bb. This observation suggests that commercial 
serological testing may lack sensitivity for accurate detection of LD 
in dogs. In light of that fact, the diagnosis of Lyme disease in pets 
should be based primarily on clinical history, such as tick exposure 
and symptomatology, including lameness, fatigue and behavioral 
changes. We recommend histological examination with silver 
nitrate staining and/or anti-Borrelia immunostaining to look for 
spirochetes in cases of canine dermopathy associated with filament 
formation. Silver nitrate staining and anti-Borrelia immunostaining 
allow for the visualization of spirochetes but cannot determine the 
identity of visible microorganisms. Consequently, PCR amplification 
ID Specimen 'DUN¿HOG Dieterle stain Bb-immunostain
C-1 Dermatological tissue N/A Spirochetes Positive spirochetes
C-1 Dermatological culture Spherules, motile spirochetes Predominantly spherules Positive spherules
C-2 Dermatological tissue N/A Spirochetes Positive spirochetes
C-2 Dermatological culture Spherules, motile spirochetes Spherules Positive spherules
C-3 Dermatological tissue N/A Spirochetes Positive spirochetes
C-4 Dermatological tissue N/A Spirochetes Weakly positive spirochetes
C-4 Dermatological culture Spherules, motile spirochetes Spirochetes, spherules Positive spirochetes, spherules
C-5 Dermatological tissue N/A Spirochetes, spherules Positive spirochetes, spherules
C-6 Dermatological tissue N/A Spirochetes, spherules Positive spirochetes, spherules
C-7 Dermatological culture Spherules, motile spirochetes Spirochetes, spherules Positive spirochetes, spherules
C-8 Dermatological culture Spherules, motile spirochetes Not performed Not performed
C-9 Dermatological culture Spherules, motile spirochetes Not performed Not performed
Table 4:0LFURVFRSLF¿QGLQJVRIGHUPDWRORJLFDOVSHFLPHQVDQGFXOWXUHV
ID Specimen Mount Allison UniversityMethod and Target
University of New Haven
Method and Target
Australian Biologics
Method and Target
C-1 Dermatological tissue (N) OspC (N) Bb 16S rRNA (RT) Bb 16S rRNA
C-1 Dermatological culture (N) OspC (N) Bb 16S rRNA
C-2 Dermatological tissue (N) OspC(N) BB 0006
C-2 Dermatological culture (N) OspC(N) BB 0006 (RT) Bb 16S rRNA
C-3 Dermatological tissue
(N) OspC
(N) BB 0006 (N) Bb pyrG sequenced – matched Bbss 99%
C-4 Dermatological culture (RT) Bb 16S rRNA
C-5 Dermatological tissue (RT) Bb 16S rRNA
C-6 Dermatological tissue (RT) Bb 16S rRNA
C-7 Dermatological culture (N) OspC (N) Bb 16S rRNA sequenced – matched Bbss 99% (RT) Bb 16S rRNA
C-8 Dermatological culture (RT) Bb 16S rRNA
C-9 Dermatological culture (RT) Bb 16S rRNA
Table 5:3&5DPSOL¿FDWLRQRIFDQLQHVXEMHFWGHUPDWRORJLFDOVSHFLPHQV$OOVSHFLPHQVWHVWHGSRVLWLYHXVLQJQHVWHG1DQGRUUHDOWLPH573&5
ID Specimen Mt Allison University University of New Haven Australian Biologics
CC-1 Dander and hair Negative (N) Negative (N) Negative (RT)
CC-2 Dander and hair Negative (N) Negative (N) Negative (RT)
CC-3 Skin biopsy Negative (N)
CC-4 Skin biopsy Negative (N)
Table 6: 3&5DPSOL¿FDWLRQRIFDQLQHFRQWUROGHUPDWRORJLFDOVSHFLPHQV$OOVSHFLPHQVWHVWHGQHJDWLYHXVLQJQHVWHG1DQGRUUHDOWLPH573&5
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of spirochetal DNA is needed to confirm the genetic identity of 
spirochetes detected in skin tissue. 
In our study, PCR analysis was performed at three independent 
laboratories in order to avoid possible contamination in a single 
laboratory and to optimize the PCR results using different techniques. 
It is important to remember that PCR is not 100% sensitive. We have 
found that false negative results can occur in clinical specimens because 
of a number of factors: DNA degradation has occurred, inhibitory 
substances are present, DNA from competing microorganisms or 
host DNA may prevent amplification of the target, and the primer 
may be too specific to detect the genetic diversity of Borrelia in clinical 
specimens. In our experience, PCR amplification and subsequent 
sequencing from veterinary skin specimens is more challenging than 
Borrelia burgdorferi strain B31, complete genome  
Sequence ID: gb|CP009656.1| Length: 910687 Number of Matches: 1 
Range 1: 588525 to 589180 GenBankGraphics 
Alignment statistics for match #1
   
 
1201 bits(650) 0.0 655/657(99%) 2/657(0%) Plus/Plus
Query  23 GATTGGGAGTGGTAATATTTCTTTTATTCATTTAACATATGTGCCAAGTCCAGCTGGAAT  82
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588525  GATTGGGAGTGGTAATATTTCTTTTATTCATTTAACATATGTGCCAAGTCCAGCTGGAAT  588584 
Query  83 TAATGAGCAAAAATCTAAACCTACTCAACAAAGTGTTAAAACCTTAAATAAAGCAGGTAT  142
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588585  TAATGAGCAAAAATCTAAACCTACTCAACAAAGTGTTAAAACCTTAAATAAAGCAGGTAT  588644 
Query  143 TTTCCCCGATTTAATTATTGCTAGAAGTTCACAAGTATTGACAGACCAAATCAGaaaaaa  202
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588645  TTTCCCCGATTTAATTATTGCTAGAAGTTCACAAGTATTGACAGACCAAATCAGAAAAAA  588704 
Query  203 aGTGGCAATGTTTTGCAATGTTGAGAGCACTTCTATTATTGACAATGTTGATGTTTCTAC  262
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588705  AGTGGCAATGTTTTGCAATGTTGAGAGCACTTCTATTATTGACAATGTTGATGTTTCTAC  588764 
Query  263 TATTTATGAAATTCCTATATCTTTTTATAAGCAGGGTGTACATGAGATTTTAAGCTCTAA  322
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588765  TATTTATGAAATTCCTATATCTTTTTATAAGCAGGGTGTACATGAGATTTTAAGCTCTAA  588824 
Query  323 GTTAAATATTAAGGTTGATCCAAAAATAGAAGAGCTTTCAAAGCTTGTAGGAGTTATAAA  382
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588825  GTTAAATATTAAGGTTGATCCAAAAATAGAAGAGCTTTCAAAGCTTGTAGGAGTTATAAA  588884 
Query  383 ATCTAAtttttttGTGCCTaaaaaaaTTATTAATATTGCTATTTGTGGTAAATATGCTGA  442
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588885  ATCTAATTTTTTTGTGCCTAAAAAAATTATTAATATTGCTATTTGTGGTAAATATGCTGA  588944 
Query  443 ACTTGATGATTCTTATGCATCAATTAGAGAGTCTTTGGTTCATGTTGCAGCCCATTTGGA  502
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  588945  ACTTGATGATTCTTATGCATCAATTAGAGAGTCTTTGGTTCATGTTGCAGCCCATTTGGA  589004 
Query  503 TTTGCTTATTAAAAGCACTTTAATTGATTCTAATGATTTAAATGAGAGCTGTTTAAAAGA  562
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  589005  TTTGCTTATTAAAAGCACTTTAATTGATTCTAATGATTTAAATGAGAGCTGTTTAAAAGA  589064 
Query  563 GTTTGACGGCATTATTGTTCCTGGCGGCTTTGGAGGCAAAGGATATGAAGGTAAAATTAT  622
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  589065  GTTTGACGGCATTATTGTTCCTGGCGGCTTTGGAGGCAAAGGATATGAAGGTAAAATTAT  589124 
Query  623 GGCTATTAAATATGCTCGTGAGAATAATATTCCCTTTCTTGGAATT-GTCCTTGGTT  678
|||||||||||||||||||||||||||||||||||||||||||||| ||| ||||||  
Sbjct  589125  GGCTATTAAATATGCTCGTGAGAATAATATTCCCTTTCTTGGAATTTGTC-TTGGTT  589180   
Figure 7A: Amplicon sequence from dermatological specimen of dog C-3. Forward sequence.
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Borrelia burgdorferi strain B31, complete genome  
Sequence ID: gb|CP009656.1| Length: 910687 Number of Matches: 1 
Range 1: 588475 to 589128 GenBankGraphics 
Alignment statistics for match #1
   
 
1195 bits(647) 0.0 653/656(99%) 2/656(0%) Plus/Minus
Query 28 AGCCATAATTTTACCTTCATATCCTTTGCCTCCAAAGCCGCCAGGAACAATAATGCCGTC  87 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct 589128 AGCCATAATTTTACCTTCATATCCTTTGCCTCCAAAGCCGCCAGGAACAATAATGCCGTC  589069  
Query 88  AAACTCTTTTAAACAGCTCTCATTTAAATCATTAGAATCAATTAAAGTGCTTTTAATAAG  147
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 589068  AAACTCTTTTAAACAGCTCTCATTTAAATCATTAGAATCAATTAAAGTGCTTTTAATAAG  589009  
Query 148 CAAATCCAAATGGGCTGCAACATGAACCAAAGACTCTCTAATTGATGCATAAGAATCATC  207
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 589008  CAAATCCAAATGGGCTGCAACATGAACCAAAGACTCTCTAATTGATGCATAAGAATCATC  588949  
Query 208 AAGTTCAGCATATTTACCACAAATAGCAATATTAATAAtttttttAGGCACaaaaaaaTT  267
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588948  AAGTTCAGCATATTTACCACAAATAGCAATATTAATAATTTTTTTAGGCACAAAAAAATT  588889  
Query 268 AGATTTTATAACTCCTACAAGCTTTGAAAGCTCTTCTATTTTTGGATCAACCTTAATATT  327
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588888  AGATTTTATAACTCCTACAAGCTTTGAAAGCTCTTCTATTTTTGGATCAACCTTAATATT  588829  
Query 328 TAACTTAGAGCTTAAAATCTCATGTACACCCTGCTTATAAAAAGATATAGGAATTTCATA  387
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588828  TAACTTAGAGCTTAAAATCTCATGTACACCCTGCTTATAAAAAGATATAGGAATTTCATA  588769  
Query 388 AATAGTAGAAACATCAACATTGTCAATAATAGAAGTGCTCTCAACATTGCAAAACATTGC  447
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588768  AATAGTAGAAACATCAACATTGTCAATAATAGAAGTGCTCTCAACATTGCAAAACATTGC  588709  
Query 448 CACtttttttCTGATTTGGTCTGTCAATACTTGTGAACTTCTAGCAATAATTAAATCGGG  507
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588708  CACTTTTTTTCTGATTTGGTCTGTCAATACTTGTGAACTTCTAGCAATAATTAAATCGGG  588649  
Query 508 GAAAATACCTGCTTTATTTAAGGTTTTAACACTTTGTTGAGTAGGTTTAGATTTTTGCTC  567
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588648  GAAAATACCTGCTTTATTTAAGGTTTTAACACTTTGTTGAGTAGGTTTAGATTTTTGCTC  588589  
Query 568 ATTAATTCCAGCTGGACTTGGCACATATGTTAAATGAATAAAAGAAATATTACCACTCCC  627
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 588588  ATTAATTCCAGCTGGACTTGGCACATATGTTAAATGAATAAAAGAAATATTACCACTCCC  588529  
Query 628 AATCTCCTGTCTTATTTGTCTTACTGTCTCAATAAATAAAATNNTTTTTCCATATC  683
||||||||||||||||||||||||||||||||||||||||||  |||| |||||||  
Sbjct 588528  AATCTCCTGTCTTATTTGTCTTACTGTCTCAATAAATAAAATA-TTTT-CCATATC  588475 
Figure 7B: Amplicon sequence from dermatological specimen of dog C-3. Reverse sequence.
amplification from human clinical specimens. We attribute this to 
the fact that there were many other bacteria present in the specimens 
that were analyzed. High levels of competing microorganisms would 
complicate the PCR process and decrease the chance of obtaining an 
amplicon of sufficient quality for sequencing. Only the skin samples 
from dogs C-3 (Golden Retriever) and C-7 (Miniature Schnauzer) 
yielded PCR amplicons that could be sequenced, and the DNA from 
those samples matched Bb sensu stricto. 
At present we do not know if Borrelia spp. are the only bacteria 
that can trigger MD filament formation. It is possible that other 
spirochetes such as Treponema pallidum or T. denticola could induce 
dermal filament production. Helicobacter pylori has been detected 
in human MD specimens by the research group at the University 
of New Haven, and Australian Biologics reported finding both T. 
denticola with Borrelia spp. in human Morgellons samples. Thus 
co-infecting pathogens or other spirochetes could be involved in 
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Figure 7C: Amplicon sequence from dermatological specimen of dog C-7. Forward sequence.
MD-type filamentous dermatological manifestations. We speculate 
that tickborne co-infections and co-involved infections such as H. 
pylori and T. denticola could be contributing secondary factors in the 
development of filamentous borrelial dermatitis. 
Dogs are susceptible to LD and serve as both disease sentinels 
and animal models to investigate human tickborne illness [2,3]. 
For this reason, accurate diagnosis is important to insure (1) that 
companion animals can receive appropriate treatment and (2) that 
accurate infection rates will reflect what is happening in the human 
population. Serological testing coupled with epidemiological and 
clinical evidence is the principal mode of estimating Lyme disease 
prevalence in canine populations [2,4,28]. In veterinary practice, the 
prevailing thought has been that the detection of anti-Bb antibodies 
may not correlate with clinical disease because of low test specificity, 
and consequently it is assumed that LD serological testing leads 
to overestimation of the canine infection rate [2]. The serological 
results of our study challenge that claim, and canine cases may in 
fact be under-reported. Some of the dogs in our study were tested 
by commercially available Lyme serological methods, and all were 
classified as being serologically negative, yet these dogs had detectible 
Borrelia spirochetes in their skin samples. Our cases illustrate the 
difficulties with currently available canine LD serological testing, 
which appear to be similar to the problems with human commercial 
LD testing [29]. 
It has been estimated that about 6% of human LD cases are 
associated with MD [30]. With over 300,000 new human LD cases 
diagnosed per year in the USA alone [31], MD may prove to be fairly 
common if increased awareness prompts physicians and veterinarians 
to look for it. Six of the dogs in our study initially presented at the 
same veterinary clinic in Alberta, a Canadian province where LD is 
considered to be extremely rare. The dogs presented to a clinic in 
which the veterinarians were familiar with the MD literature and 
included LD in the differential diagnosis. The lack of LD awareness 
coupled with the misperception that it is rare or non-existent in 
various geographical areas of the USA and Canada, and compounded 
by insensitive Lyme serological testing, may cause animal and human 
LD to go undiagnosed. If MD is proved to be pathognomonic for LD, 
the dermopathy may be important in assessing the sensitivity of Lyme 
serological testing in both dogs and humans and may aid in more 
accurate estimates of infection. 
MD lesions have been attributed to delusions of parasitosis or 
delusional infestation (DI), and many healthcare practitioners are 
under the impression that the lesions are caused by self-mutilation 
and implantation of textile fibers [18,19,32]. Recognition of MD in 
humans as a true somatic illness has met with vehement opposition 
by the mainstream medical community [18,19,32], even in the face 
of published evidence demonstrating an association with LD and 
the detection and isolation of Bb spirochetes from lesions of MD 
patients [19]. “DI by proxy” and “double DI” are terms that have 
been introduced to explain cases of suspected MD-like illness in 
pets presenting at veterinary practices [33]. Just as MD is commonly 
thought by medical professionals to be a type of DI, filamentous 
borrelial dermatitis occurring in pets may be misdiagnosed as “DI 
by proxy” or “double DI” by veterinarians, especially if the pet owner 
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Borrelia burgdorferi strain B31, complete genome  
Sequence ID: gb|CP009656.1|Length: 910687Number of Matches: 1 
Range 1: 445623 to 445996GenBankGraphics Next Match Previous Match 
Alignment statistics for match #1
   
 
675 bits(365)0.0 373/376(99%)3/376(0%)Plus/Minus
Query  23 GTGGCGAACGGGTGAGTAACGCGTGGATGATCTACCTATGAGATGGGGATAACTATTAGA  82
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  445996 GTGGCGAACGGGTGAGTAACGCGTGGATGATCTACCTATGAGATGGGGATAACTATTAGA  445937  
Query  83 AATAGTAGCTAATACCGAATAAGGTCAGTTAATTTGTTAATTGATGAAAGGAAGCCTTTA  142
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  445936 AATAGTAGCTAATACCGAATAAGGTCAGTTAATTTGTTAATTGATGAAAGGAAGCCTTTA  445877  
Query  143 AAGCTTCGCTTGTAGATGAGTCTGCGTCTTATTAGCTAGTTGGTAGGGTAAATGCCTACC  202
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  445876 AAGCTTCGCTTGTAGATGAGTCTGCGTCTTATTAGCTAGTTGGTAGGGTAAATGCCTACC  445817  
Query  203 AAGGCAATGATAAGTAACCGGCCTGAGAGGGTGAACGGTCACACTGGAACTGAGATACGG  262
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  445816 AAGGCAATGATAAGTAACCGGCCTGAGAGGGTGAACGGTCACACTGGAACTGAGATACGG  445757  
Query  263 TCCAGACTCCTACGGGAGGCAGCAGCTAAGAATCTTCCGCAATGGGCGAAAGCCTGACGG  322
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  445756 TCCAGACTCCTACGGGAGGCAGCAGCTAAGAATCTTCCGCAATGGGCGAAAGCCTGACGG  445697  
Query  323 AGCGACACTGCGTGAATGAAGAAGGTCGAAAGATTGTAAAATTCTTTTATAAATGAGGAA  382
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  445696 AGCGACACTGCGTGAATGAAGAAGGTCGAAAGATTGTAAAATTCTTTTATAAATGAGGAA  445637  
Query  383 TA-GCTTTTTGTAGGA  397
|| |||||  |||||| 
Sbjct  445636 TAAGCTTT--GTAGGA  445623   
Figure 7D: Amplicon sequence from dermatological specimen of dog C-7. Reverse sequence.
displays symptoms such as anxiety, depression or agitated behavior. 
Spirochetal infection in humans can cause neuropsychiatric 
symptoms that, coupled with strange crawling and stinging sensations 
with long filaments projecting from skin, leads some people afflicted 
with MD to erroneously believe they are infested with insects or 
parasites [20]. Objective consideration must be maintained to achieve 
an accurate differential diagnosis when an owner afflicted with MD 
presents a pet with this unusual dermopathy to the veterinarian. 
When insect infestation and/or parasitosis without evidence of these 
conditions is proposed by a pet owner as a diagnosis, LD should 
be considered in the differential diagnosis before giving the pet a 
diagnosis of “DI by proxy” and dismissing the pet owner as being 
delusional. 
The presence of Borrelia spirochetes in MD appears to be a primary 
etiologic factor for MD development in humans, but the etiology may 
be multifactorial [13-15]. For example, MD is more frequently seen 
in middle-aged Caucasian women than in other population groups, 
so race, gender and age may play an etiologic role [12]. However, the 
etiology of MD is poorly understood, and secondary etiologic factors 
remain to be elucidated. Secondary etiologic factors may also play 
a role in canine skin disease. Although the number of dogs in our 
study was relatively small, interestingly we had a Golden Retriever, 
two Schnauzers and four Bulldog-type dogs. Golden and Labrador 
Retrievers are known to develop glomerulonephritis associated with 
LD and therefore may be predisposed to develop a more severe 
form of tickborne disease compared to other dog breeds [7]. The 
Schnauzers in our study had light coats that are associated with color 
dilution gene mutations, which in turn are associated with increased 
skin sensitivity [34]. Furthermore, Bulldogs and Golden Retrievers 
are breeds that are genetically predisposed to develop ichthyosis, a 
dermopathy characterized by rough, dry, scaly skin [35]. In our study 
group, both male and female dogs were present in equal numbers and 
in this respect the filamentous dermopathy appears to differ from 
human MD, where the manifestation appears to be more common 
in women. The fact that almost all the pets in our study were spayed 
and/or neutered, however, may account for the fact that there was no 
female predominance in these animals.
As noted above, human MD occurs in about 6% of patients with 
LD [30]. This observation suggests that one or more genetic factors 
may determine the occurrence of the dermopathy in LD patients. The 
fact that canine MD appears to preferentially affect certain breeds of 
dogs suggests that similar genetic factors may be important for the 
development of canine MD in the presence of Borrelia infection. 
Further studies of genomic variation in these animals may help to 
unlock the mystery of MD in human subjects.
This preliminary study had a number of limitations. No 
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laboratory method for detecting pathogens in bodily fluids and 
tissues is 100% sensitive and specific. Therefore, we relied on different 
methodologies that collectively provided corroborative evidence of 
Borrelia infection in this cohort of dogs. We note that the antibody 
Abcam ab20950 is known to cross-react with Treponema pallidum, 
B. hermsii and B. parkerii and may cross-react with Mycobacterium 
tuberculosis; however, we chose this antibody for immunostaining 
instead of a Bb-specific monoclonal antibody because filamentous 
dermatitis could be caused by one of the Bb sensu lato species, or even 
a treponeme. Using a monoclonal antibody that was Borrelia strain-
specific could have produced false-negative results. In consideration 
of the above, the PCR amplification of DNA targets performed in 
this study provided a more specific method to detect Borrelia spp. in 
clinical specimens, and PCR testing yielded putative or, in the cases 
of dogs C-3 and C-7, conclusive genetic identifications. In summary, 
although the immunostaining lacked specificity, the evidence 
presented by immunostaining was supported by the results obtained 
by PCR amplification of Borrelia DNA targets.
Another limitation of our study was that we had only a small 
cohort of dogs. In addition, our study does not reflect the geographical 
distribution of known cases of canine LD. The study was performed 
in Alberta, Canada, because veterinarians at Heartland Veterinary 
Clinic in Airdrie, Alberta were familiar with the MD literature and, 
upon noticing cases in dogs with lesions similar to MD in humans, 
approached the other authors to collaborate on a study. In view of 
these sampling and geographical limitations, we acknowledge that 
some of our observations and conclusions may be open to other 
interpretations, but the provocative results of our preliminary study 
suggest that further investigation is warranted.
Conclusions
Analysis performed at five independent laboratories provided 
compelling, corroborative evidence that a dermopathy comparable 
to the human condition referred to as Morgellons disease can also 
occur in dogs. Domestic pets may present at veterinary clinics with 
filamentous dermopathy associated with spirochetal infection, 
and this manifestation appears to be analogous to MD in humans. 
Veterinarians should consider MD or LD in their differential 
diagnosis when presented with cases of unusual dermopathy 
that lack other explanations, particularly if unusual filaments 
are visible in epidermal lesions or are embedded under the skin. 
Serological testing should not be relied upon for diagnosis of 
LD. Direct detection of spirochetes in dermatological tissue by 
histology or PCR amplification of DNA may be more useful than 
serology to obtain a LD diagnosis in these pets. 
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